Drug recall · December 27, 2017
Neostigmine Methylsulfate recall
Why: Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613, NDC# 69623-234-15
- Lots / codes
Lot # NEO071317MMDSA BUD: 01/19/2018 Lot # NEO071317MMDSC BUD: 01/19/2018 Lot # NEO071317MMDSF BUD: 01/19/2018
- Quantity
- 1610 syringes
- Company
- Premier Pharmacy Labs Inc, Weeki Wachee, FL
- Distribution
- Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida
- Initiated
- August 10, 2017 · Voluntary: Firm initiated
- Classified
- December 21, 2017
- Reported
- December 27, 2017
- Ended
- March 29, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Neostigmine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.